Author:
Shigeno Takashi,Kajiyama Daisuke,Sato Kazuma,Fujiwara Naoto,Kinugasa Yusuke,Daiko Hiroyuki,Fujita Takeo
Publisher
Springer Science and Business Media LLC
Reference16 articles.
1. Tanaka K, Yano M, Motoori M, Doki Y, Kishi K, Miyashiro I, et al. The significance of abdominal para-aortic lymph node metastasis in patients with lower thoracic esophageal cancer. Dis Esophagus. 2012;25(2):146–52.
2. Shimada Y, Imamura M, Sato F, Maeda M, Kaganoi J, Hashimoto Y, et al. Indications for abdominal para-aortic lymph node dissection in patients with esophageal squamous cell carcinoma. Surgery. 2002;132(1):93–9.
3. Kuga Y, Kitamura S, Mouri T, Miwata T, Sakimoto H, Nishida T. A case of resected advanced esophageal cancer that responded to combination therapy comprising docetaxel, cisplatin, and 5-fluorouracil. Jpn J Cancer Chemother. 2017;44(3):247–9.
4. Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, et al. New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45:228–47.
5. Japanese Esophageal Society. Japanese Classification of Esophageal Cancer, 12th Edition.